Metabolic syndrome treatment: focusing on acarbose
Aim. To compare the effectiveness of alpha-glucosidase inhibitor acarbose (150 or 300 mg/d) and non-pharmaceutical lifestyle modification in controlling arterial hypertension (AH), carbohydrate and lipid metabolism, and body weight (BW) among patients with impaired glucose tolerance (IGT) and AH.Mat...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
«SILICEA-POLIGRAF» LLC
2008-04-01
|
| Sarja: | Кардиоваскулярная терапия и профилактика |
| Aiheet: | |
| Linkit: | https://cardiovascular.elpub.ru/jour/article/view/1331 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|